{"id":37313,"date":"2025-07-15T14:43:19","date_gmt":"2025-07-15T06:43:19","guid":{"rendered":"https:\/\/flcube.com\/?p=37313"},"modified":"2025-07-15T14:45:05","modified_gmt":"2025-07-15T06:45:05","slug":"hunan-mabgeek-biotech-files-for-hong-kong-ipo-to-expand-innovative-biologics-pipeline","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=37313","title":{"rendered":"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline"},"content":{"rendered":"\n<p>China-based Hunan Mabgeek Biotech Co., Ltd has submitted an application to the Hong Kong Stock Exchange to float its shares on the bourse. This move is expected to support the company&#8217;s ongoing development and commercialization efforts of innovative biologics targeting allergic and autoimmune diseases, as well as other inflammatory and immune-related disorders. <\/p>\n\n\n\n<p><strong>About Mabgeek Biotech<\/strong><br>Founded in 2016, Mabgeek Biotech is a regulatory and clinical stage biopharmaceutical company dedicated to discovering, developing, and commercializing innovative biologics. The company has established a robust pipeline of eight innovative drug candidates, all of which are next-generation long-acting antibodies developed through its proprietary technology platforms.<\/p>\n\n\n\n<p><strong>Pipeline Highlights<\/strong><br>Mabgeek&#8217;s core product, MG-K10, is a potentially best-in-class, self-developed, long-acting anti-IL-4R\u03b1 antibody currently at the registration clinical stage. The company is conducting or planning clinical trials for eight indications, including atopic dermatitis and asthma. Other key products in the pipeline include MG-014 and MG-013, further underscoring the company&#8217;s commitment to addressing significant unmet medical needs.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/sehk25071401160_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of sehk25071401160_c.\"><\/object><a id=\"wp-block-file--media-46c66a73-6958-4d11-81df-5a8735da2f86\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/sehk25071401160_c.pdf\">sehk25071401160_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/sehk25071401160_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-46c66a73-6958-4d11-81df-5a8735da2f86\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>China-based Hunan Mabgeek Biotech Co., Ltd has submitted an application to the Hong Kong Stock&#8230;<\/p>\n","protected":false},"author":1,"featured_media":37317,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[72,3310],"class_list":["post-37313","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-ipo","tag-mabgeek-biotechnology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Hunan Mabgeek Biotech Co., Ltd has submitted an application to the Hong Kong Stock Exchange to float its shares on the bourse. This move is expected to support the company&#039;s ongoing development and commercialization efforts of innovative biologics targeting allergic and autoimmune diseases, as well as other inflammatory and immune-related disorders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=37313\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline\" \/>\n<meta property=\"og:description\" content=\"China-based Hunan Mabgeek Biotech Co., Ltd has submitted an application to the Hong Kong Stock Exchange to float its shares on the bourse. This move is expected to support the company&#039;s ongoing development and commercialization efforts of innovative biologics targeting allergic and autoimmune diseases, as well as other inflammatory and immune-related disorders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=37313\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-15T06:43:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-15T06:45:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1502.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37313#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37313\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline\",\"datePublished\":\"2025-07-15T06:43:19+00:00\",\"dateModified\":\"2025-07-15T06:45:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37313\"},\"wordCount\":181,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37313#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1502.webp\",\"keywords\":[\"IPO\",\"MabGeek Biotech\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=37313#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37313\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=37313\",\"name\":\"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37313#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37313#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1502.webp\",\"datePublished\":\"2025-07-15T06:43:19+00:00\",\"dateModified\":\"2025-07-15T06:45:05+00:00\",\"description\":\"China-based Hunan Mabgeek Biotech Co., Ltd has submitted an application to the Hong Kong Stock Exchange to float its shares on the bourse. This move is expected to support the company's ongoing development and commercialization efforts of innovative biologics targeting allergic and autoimmune diseases, as well as other inflammatory and immune-related disorders.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37313#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=37313\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37313#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1502.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1502.webp\",\"width\":1080,\"height\":608,\"caption\":\"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37313#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline - Insight, China&#039;s Pharmaceutical Industry","description":"China-based Hunan Mabgeek Biotech Co., Ltd has submitted an application to the Hong Kong Stock Exchange to float its shares on the bourse. This move is expected to support the company's ongoing development and commercialization efforts of innovative biologics targeting allergic and autoimmune diseases, as well as other inflammatory and immune-related disorders.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=37313","og_locale":"en_US","og_type":"article","og_title":"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline","og_description":"China-based Hunan Mabgeek Biotech Co., Ltd has submitted an application to the Hong Kong Stock Exchange to float its shares on the bourse. This move is expected to support the company's ongoing development and commercialization efforts of innovative biologics targeting allergic and autoimmune diseases, as well as other inflammatory and immune-related disorders.","og_url":"https:\/\/flcube.com\/?p=37313","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-07-15T06:43:19+00:00","article_modified_time":"2025-07-15T06:45:05+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1502.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=37313#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=37313"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline","datePublished":"2025-07-15T06:43:19+00:00","dateModified":"2025-07-15T06:45:05+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=37313"},"wordCount":181,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=37313#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1502.webp","keywords":["IPO","MabGeek Biotech"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=37313#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=37313","url":"https:\/\/flcube.com\/?p=37313","name":"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=37313#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=37313#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1502.webp","datePublished":"2025-07-15T06:43:19+00:00","dateModified":"2025-07-15T06:45:05+00:00","description":"China-based Hunan Mabgeek Biotech Co., Ltd has submitted an application to the Hong Kong Stock Exchange to float its shares on the bourse. This move is expected to support the company's ongoing development and commercialization efforts of innovative biologics targeting allergic and autoimmune diseases, as well as other inflammatory and immune-related disorders.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=37313#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=37313"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=37313#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1502.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1502.webp","width":1080,"height":608,"caption":"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=37313#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Hunan Mabgeek Biotech Files for Hong Kong IPO to Expand Innovative Biologics Pipeline"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1502.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37313","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=37313"}],"version-history":[{"count":2,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37313\/revisions"}],"predecessor-version":[{"id":37318,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37313\/revisions\/37318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/37317"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=37313"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=37313"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=37313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}